SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-016566
Filing Date
2019-08-13
Accepted
2019-08-13 16:27:46
Documents
3
Period of Report
2019-08-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dmtp20190812_8k.htm 8-K 29242
2 EXHIBIT 99.1 ex_154943.htm EX-99.1 205505
3 logo01.jpg GRAPHIC 18167
  Complete submission text file 0001437749-19-016566.txt   261154
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36291 | Film No.: 191021011
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1